These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 18172310)

  • 1. PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells.
    Fazio G; Palmi C; Rolink A; Biondi A; Cazzaniga G
    Cancer Res; 2008 Jan; 68(1):181-9. PubMed ID: 18172310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.
    Imoto N; Hayakawa F; Kurahashi S; Morishita T; Kojima Y; Yasuda T; Sugimoto K; Tsuzuki S; Naoe T; Kiyoi H
    J Biol Chem; 2016 Feb; 291(9):4723-31. PubMed ID: 26703467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice.
    Jamrog L; Chemin G; Fregona V; Coster L; Pasquet M; Oudinet C; Rouquié N; Prade N; Lagarde S; Cresson C; Hébrard S; Nguyen Huu NS; Bousquet M; Quelen C; Brousset P; Mancini SJC; Delabesse E; Khamlichi AA; Gerby B; Broccardo C
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10357-10362. PubMed ID: 30257940
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5.
    Bousquet M; Broccardo C; Quelen C; Meggetto F; Kuhlein E; Delsol G; Dastugue N; Brousset P
    Blood; 2007 Apr; 109(8):3417-23. PubMed ID: 17179230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the Janus-faced transcription factor PAX5-JAK2 in acute lymphoblastic leukemia.
    Schinnerl D; Fortschegger K; Kauer M; Marchante JR; Kofler R; Den Boer ML; Strehl S
    Blood; 2015 Feb; 125(8):1282-91. PubMed ID: 25515960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXP1 and PAX5 are rare but recurrent translocations partners in acute lymphoblastic leukemia.
    Put N; Deeren D; Michaux L; Vandenberghe P
    Cancer Genet; 2011 Aug; 204(8):462-4. PubMed ID: 21962897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TEL/AML1 overcomes drug resistance through transcriptional repression of multidrug resistance-1 gene expression.
    Asakura K; Uchida H; Miyachi H; Kobayashi H; Miyakawa Y; Nimer SD; Takahashi H; Ikeda Y; Kizaki M
    Mol Cancer Res; 2004 Jun; 2(6):339-47. PubMed ID: 15235109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional Expression of E2A-HLF Induces B-Cell Precursor Death and Myeloproliferative-Like Disease in Knock-In Mice.
    Duque-Afonso J; Smith KS; Cleary ML
    PLoS One; 2015; 10(11):e0143216. PubMed ID: 26588248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reduced and altered activities of PAX5 are linked to the protein-protein interaction motif (coiled-coil domain) of the PAX5-PML fusion protein in t(9;15)-associated acute lymphocytic leukemia.
    Qiu JJ; Chu H; Lu X; Jiang X; Dong S
    Oncogene; 2011 Feb; 30(8):967-77. PubMed ID: 20972455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBF1 and Pax5 safeguard leukemic transformation by limiting IL-7 signaling, Myc expression, and folate metabolism.
    Ramamoorthy S; Kometani K; Herman JS; Bayer M; Boller S; Edwards-Hicks J; Ramachandran H; Li R; Klein-Geltink R; Pearce EL; Grün D; Grosschedl R
    Genes Dev; 2020 Nov; 34(21-22):1503-1519. PubMed ID: 33004416
    [No Abstract]   [Full Text] [Related]  

  • 11. Aberrant expression of CD19 in AML with t(8;21) involves a poised chromatin structure and PAX5.
    Walter K; Cockerill PN; Barlow R; Clarke D; Hoogenkamp M; Follows GA; Richards SJ; Cullen MJ; Bonifer C; Tagoh H
    Oncogene; 2010 May; 29(20):2927-37. PubMed ID: 20208555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments.
    Nutt SL; Morrison AM; Dörfler P; Rolink A; Busslinger M
    EMBO J; 1998 Apr; 17(8):2319-33. PubMed ID: 9545244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia.
    Duque-Afonso J; Feng J; Scherer F; Lin CH; Wong SH; Wang Z; Iwasaki M; Cleary ML
    J Clin Invest; 2015 Sep; 125(9):3667-80. PubMed ID: 26301816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The paired box domain gene PAX5 is fused to ETV6/TEL in an acute lymphoblastic leukemia case.
    Cazzaniga G; Daniotti M; Tosi S; Giudici G; Aloisi A; Pogliani E; Kearney L; Biondi A
    Cancer Res; 2001 Jun; 61(12):4666-70. PubMed ID: 11406533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia.
    Tiacci E; Pileri S; Orleth A; Pacini R; Tabarrini A; Frenguelli F; Liso A; Diverio D; Lo-Coco F; Falini B
    Cancer Res; 2004 Oct; 64(20):7399-404. PubMed ID: 15492262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ph-like acute lymphoblastic leukemia with a novel PAX5-KIDINS220 fusion transcript.
    Sakamoto K; Imamura T; Kanayama T; Yano M; Asai D; Deguchi T; Hashii Y; Tanizawa A; Ohshima Y; Kiyokawa N; Horibe K; Sato A
    Genes Chromosomes Cancer; 2017 Apr; 56(4):278-284. PubMed ID: 27870151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAX5 fusion genes in acute lymphoblastic leukemia: A literature review.
    Fouad FM; Eid JI
    Medicine (Baltimore); 2023 May; 102(20):e33836. PubMed ID: 37335685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus.
    Souabni A; Jochum W; Busslinger M
    Blood; 2007 Jan; 109(1):281-9. PubMed ID: 16968900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients.
    Cazzaniga V; Bugarin C; Bardini M; Giordan M; te Kronnie G; Basso G; Biondi A; Fazio G; Cazzaniga G
    Oncotarget; 2015 Jan; 6(3):1569-81. PubMed ID: 25595912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia.
    Firtina S; Sayitoglu M; Hatirnaz O; Erbilgin Y; Oztunc C; Cinar S; Yildiz I; Celkan T; Anak S; Unuvar A; Devecioglu O; Timur C; Aydogan G; Akcay A; Atay D; Turkkan E; Karaman S; Orhaner B; Sarper N; Deniz G; Ozbek U
    Leuk Res; 2012 Jan; 36(1):87-92. PubMed ID: 21813177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.